U.K. cash incentives for generics-switching draw fire; Sanofi settles more Eloxatin patent suits;

@FiercePharma: Final Four coach did time as pharma sales rep. Article | Follow @FiercePharma

> The U.K.'s National Health Service risks losing millions of pounds after a European legal opinion that calls for a ban on the growing practice of paying doctors to persuade them to prescribe cheaper generic medicines. Report

> Sanofi-Aventis has settled patent infringement suits with three more generic drugmakers over its cancer drug Eloxatin, putting off their copycat versions till August 2012. Report

> For the second time in six months, Merck is going to court to defend its patents for Cancidas, an intravenous drug that treats life-threatening fungal infections, against generic competitors. Report

> The FDA approved a reformulated version of the powerful painkiller OxyContin that is designed to make it harder to tamper with the product. Release | Report

> Many children starting treatment with atypical antipsychotics don't get the recommended glucose and lipid screening, an Archives of Pediatric and Adolescent Medicine study found. Report 

> Dishman Pharmaceuticals & Chemicals, an Indian drugmaker, plans to raise 750 million rupees ($17 million) next month selling non-convertible bonds to build new plants, Managing Director J.R. Vyas said. Report

> The Drug Controller General of India has asked Dr Reddy's Laboratories to provide details about its relationships with doctors in the wake of revised conflicts-of-interest guidelines from the Medical Council of India. Report

> A growing number of overdoses of legal opioids, sedatives and tranquilizers led to a 65 percent increase in hospitalizations over seven years. Report

Biotech News

 @FierceBiotech: Florida city carves out 1-square-mile biotech hub. Article | Follow @FierceBiotech

 @JohnCFierce: Biotech Deal Activity Takes a Breather. It's been too quiet on that front. I hate dull. Report | Follow @JohnCFierce

> Tengion braves a chilly market with $41 million IPO. Article

> Is ailing Antisoma a prime new takeover target? Item

> GSK, Crucell join R&D forces on new malaria vaccine. Story

> A blockbuster FDA deadline looms and Dendreon shares turn red-hot. Report

Manufacturing News

> MIT's Hockfield: "Time to get busy reinventing manufacturing." Report

> Chinese regulator faces bribery charge in vaccine scandal. Story

> Perrigo loses $400,000 in drug shipment theft. Item

> Report: Add REMS to Sentinel System. Story

Biotech Research News

> Explosion of cancer drug trials spurs a new approach. Story

> Researchers find "weak link" in Alzheimer's therapies. Report

> A research team in the U.K. is proposing that a new group of synthetic molecules could play a lead role fighting cancer, inflammation and other diseases. Story

> Lab breakthrough opens door to new generation of antibiotics. Item

> Genetics research pointing to new longevity drug pathways. Article

And Finally... Demand for prescription assistance in the U.S. has increased sharply following the 2008 economic crisis. Report